Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-003711
Filing Date
2021-03-29
Accepted
2021-03-29 07:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 34564
2 filename2.txt TEXT-EXTRACT 11793
  Complete submission text file 0000000000-21-003711.txt   60031
Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Filed for) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations